Abstract Human noroviruses (HuNoVs) are a leading cause of acute gastroenteritis. Establishment of a cell culture system for in vitro HuNoV growth remains challenging. Replication of HuNoVs in human intestinal cell lines (INT-407 and Caco-2) that differentiate to produce microvilli in rotation wall vessel (RWV) three-dimensional cultures has been reported (Straub et al. in Emerg Infect 
Introduction
Acute gastroenteritis remains a major disease burden worldwide, with an estimated 1.7 billion episodes annually [22, 25] . Human noroviruses (HuNoVs) are the leading cause of food-borne gastroenteritis in the US, accounting for 58 % of all cases [36] . It has been estimated that HuNoVs cause up to 200,000 deaths of children \5 years of age in developing countries annually [31] . HuNoVs belong to the family Caliciviridae and have a single-stranded, positive-sense RNA genome. Noroviruses are genetically diverse and are classified into five genogroups (GI-GV). Viruses within each genogroup are further divided into genotypes based on sequence similarity. GI, GII and GIV are associated with human infections [46] . There are more than 30 genotypes, with the GI.1/Norwalk strain being the prototype and GII.4 being the dominant genotype worldwide, responsible for 70-80 % of HuNoV outbreaks [13] . The lack of an efficient cell culture system for HuNoVs has greatly hampered an understanding of their life cycle and the development of antiviral drugs and vaccines [10] .
Human volunteer studies have provided information on HuNoV pathogenesis, including the following observations: (1) The primary site for viral replication was the small intestine, with blunting and shortening of villi, which was observed by intestinal biopsy from individuals inoculated with GI.1/Norwalk virus [1] . (2) Individuals who have inactive a (1, 2) fucosyltransferase (FUT2) genes were resistant to Norwalk virus infection [19, 24, 42] . Those who have active FUT2 are called secretors (Se ? ), expressing histo-blood group antigens (HBGAs) not only on red blood cells but also on the surface of mucosal epithelial cells and in body fluids such as saliva [42] . Thus, HBGAs are considered receptors/co-receptors for Norwalk virus. Although HBGAs are present in the human colorectal adenocarcinoma cell line Caco-2 [2, 15, 16] , the use of this cell line in conventional cultures has failed to support HuNoV replication [10] . Because human volunteer studies are difficult and expensive, continuous efforts are being made to establish an in vitro cell culture system for HuNoVs. A novel approach was reported recently by Lay et al. [23] by using primary macrophages and dendritic cells from peripheral blood mononuclear cells of Se individuals. However, Norwalk virus failed to replicate in these cells and showed a different cell tropism from that of murine NoV, which replicates in mouse macrophages and dendritic cells [23, 43] .
Most publications reporting attempts to establish a cell culture system for HuNoVs have shown negative results [10, 23, 29] , except for sequential papers from a single group who reported successful HuNoV replication in a three-dimensional (3-D) culture model using human intestinal epithelial cell lines, INT-407 and Caco-2 cells [37] [38] [39] . The authors reported that the critical factor for HuNoV replication in these cells was having apical microvillus structures [39] . In the present study, we report contradictory results using a similar 3-D culture system with the same GI.1/Norwalk virus strain as well as two additional HuNoV strains, GII.4/HS194, belonging to the dominant genotype, and GII.12/HS206, an emerging genotype [41] .
Materials and methods

3-D culture of human intestinal cell lines
The human epithelial cell line INT-407 (ATCC #CCL-6, HeLa contaminant) was cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10 % fetal bovine serum (FBS) and antibiotics (100 units of penicillin, 100 lg of streptomycin, and 0.25 lg of amphotericin B per ml). The human colorectal adenocarcinoma cell line Caco-2 (ATCC #HTB-37) was cultured in minimal essential medium (MEM) supplemented with 20 % FBS, 1 % nonessential amino acids, 1 mM sodium pyruvate, and antibiotics. Fetal bovine serum was from Thermo Scientific (Waltham, MA, USA), and the other reagents were from Invitrogen (Carlsbad, CA, USA). Three-D cultures were established according to the techniques described previously [27, 37, 38] . Briefly, a total of *2 9 10 6 cells were loaded into a rotating wall vessel (RWV) bioreactor (Synthecon, Inc., Houston, TX, USA) containing 250 mg of Cytodex 2-trimethyl-2-hydroxyaminopropyl-coated microcarrier beads or Cytodex 3 porous collagen I-coated microcarrier beads (Sigma, St. Louis, MO, USA) and incubated at 37°C in 5 % CO 2 . Vessel rotation was initiated at 15 rotations per minute, and the rotation speed was increased as aggregate size increased to maintain cell aggregates in free-fall suspension. Partial growth medium was replaced every 48-72 hours. Cell aggregates were harvested at 21-28 days after seeding using a wide-bore pipette and rinsed three times with 0.01 M phosphate-buffered saline (PBS, pH 7.2). After confirming a viability of greater than 95 % by trypan blue exclusion, cell aggregates were used for HuNoV replication trials in 24-well tissue culture plates (50 ll, with 2-3 aggregates/well, *5,000 cells/well). Basically, we aimed to follow the same approach and set-up described by Straub and colleagues [37, 38] except that we attempted using additional materials such as Cytodex 2 microcarrier beads, additional HuNoV genotype strains as inocula, culture medium supplements and an additional inoculation method described in the following section.
HuNoV stocks and infection trials
Three strains of HuNoVs were used in infection trials: (1) Human-volunteer-passaged Hu/NoV/GI.1/Norwalk/1968/ US (GenBank accession number M87661), which was generously provided by Dr. Mary Estes of Baylor College of Medicine (Houston, Texas), (2) Hu/NoV/GII.4/HS194/ 2010/US (GenBank accession number GU325839) [41] , and (3) Hu/NoV/GII.12/HS206/2010/US (GenBank accession number HQ664990) [41] . The original stool samples were suspended in sterile MEM at 10 % (w/v) and were processed by vigorous vortexing, centrifugation at 1,800 9 g for 30 min, and filtration through 0.2-lm-poresize filters. These samples were screened for common diarrheal viruses, including NoV GI and GII, human rotavirus groups A, B and C, sapovirus, astrovirus, and adenovirus by RT-PCR or PCR assays as described previously [21, 44, 45] . The suspensions were aliquoted to individual tubes, stored at -70°C, and thawed only once for infection trials. The viral RNA titer of each sample was determined using real-time reverse transcription PCR (RT-qPCR). For virus inoculation, approximately 4 log 10 genomic equivalents (GE)/cell (*5 9 10 7 GE/well) were applied in 100 ll of sample for a total volume of 150 ll/well, as used by Straub et al. [38] and indicated to be important to allow maximal viral contact with the cell suspension. Serum-free media were used as mock controls. Plates were gently rocked every 15 minutes during the 1-hour absorption phase. Subsequently, all wells were overlaid with an additional 1 ml of fresh serum-free medium. Plates were incubated at 37°C in 5 % CO 2 . At 0, 24, 48, 72, and 96 hours post-inoculation (hpi), culture supernatants were harvested for viral RNA assays. At 24 hpi, plates were fixed and examined for viral antigens by immunofluorescence assays. Three wells were allocated for each condition per experiment, and experiments were repeated at least twice. For some trials, direct inoculation to the RWV was performed, as has been shown to be effective for rhinovirus [26] and hepatitis C virus replication [35] . In addition, culture supplements that have been effective for the growth of fastidious enteric viruses in vitro were also added at the time of inoculation to determine their influence on supporting HuNoV replication. These supplements included 2 % intestinal content preparations (IC) from gnotobiotic pigs [12, 30] , 100 lM glycochenodeoxycholic acid (GCDCA, Sigma, St. Louis, MO, USA) [7] , and 1 lM simvastatin (Zocor; Merck and Co, Inc., Whitehouse station, NJ) [8, 20, 33] .
Viral RNA extraction and TaqMan RT-qPCR RNA was extracted from samples by using a MagMAX Viral RNA Isolation Kit (Applied Biosystems, Foster City, CA, USA) or an RNeasy Mini Kit (QIAGEN, Valencia, CA, USA) according to the manufacturer's instructions. All of the NoV-positive samples were titrated in duplicate by RT-qPCR [21] with a standard curve generated from a serial dilution of an RNA transcript, which was generously provided by Dr. Estes (Prep1397FN, GI.1/Norwalk virus ORF1/2) for NoV GI and plasmid DNA carrying the GII.4/ HS66-specific COG2F/2R amplicon for NoV GII.
Production of guinea pig hyperimmune serum Hyperimmune serum to virus-like particles (VLPs) of GII.12/HS206 strain [41] was prepared according to an approved IACUC protocol as described previously [9] .
Microscopic analysis
The cellular histology of mature 3-D aggregates was monitored using an Olympus inverted microscope system (Olympus, Tokyo, Japan) before and after the inoculation trials. To assess the subcellular pathology, cell aggregates harvested from a vessel were prepared and examined as described previously [34, 37, 38] . Samples were fixed in 3 % glutaraldehyde-1 % paraformaldehyde in 0.1 M potassium phosphate buffer (PPB; pH 7.2) for 2 to 3 hours at room temperature. Samples were washed three times with excess PPB and then post-fixed with 1 % osmium tetroxide and 1 % uranyl acetate in distilled water for 1 h at room temperature. After dehydration in a graded ethanolpropylene oxide series, samples were embedded in EM Bed-812 resin (Electron Microscopy Sciences, Hartfield PA, Cat. #14120). Two-lm sections were collected, stained with 0.5 % toluidine blue in 25 % ethanol and 0.1 % sodium carbonate solution, viewed with a Leica DM IRB light microscope (Leica, Solms, Germany), and imaged with a Retiga 2000R digital camera (Scientifica, East Sussex, UK). On 200-nm mesh copper grids, 70-nm thin sections were collected, stained with 2 % aqueous uranyl acetate and Reynolds' lead citrate stain, and viewed using a Hitachi H-7500 (Hitachi, Tokyo, Japan) transmission electron microscope. Images were captured with an Optronics QuantiFire model S99835 digital camera [9] .
For analysis by confocal microscopy, cell aggregates harvested from a cell culture plate at 24 hpi were fixed with 4 % paraformaldehyde and 0.2 % glutaraldehyde in 0.1 M PPB for 2 h at room temperature, washed four times with PPB, and quenched with PPB containing 50 mM glycine for 1 h at room temperature or kept overnight at 4°C. After permeabilization with 0.1 % Triton X-100 in PBS for 1 h at room temperature, cells were washed with PBS, blocked with PBS containing 2 % bovine serum albumin and 5 % normal goat serum for 30 min at room temperature, and incubated with genotype-specific primary antibodies overnight at 4°C in incubation buffer (10 mM PPB containing 150 mM NaCl, 10 mM sodium azide, and 0.2 % bovine serum albumin). The primary antibodies used were anti-GI.1/Norwalk polyclonal antibody produced in a rabbit, anti-GII.4/Houston monoclonal antibody produced in a mouse (both kindly provided by Dr. Estes), anti-GII.4/ HS194 polyclonal antibody produced in a guinea pig [20] and anti-GII.12/HS206 polyclonal antibody produced in a guinea pig at dilutions of 1:800, 1:500, 1:800, and 1:800, respectively. After six washes with PBS, incubation with a 1:600 dilution of a secondary antibody (goat anti-rabbit IgG labeled with Alexa Fluor 488, goat anti-mouse IgG labeled with Alexa Fluor 488, or goat anti-guinea-pig IgG labeled with Alexa Fluor 543) was performed overnight at 4°C. All of the secondary antibodies were from Invitrogen. Samples were counterstained with the nuclear stain diamidino-2-phenylindole (DAPI), giving a blue color, and the cytoskeleton stain Alexa Fluor 633-labeled phalloidin, producing a cyan color (both from Invitrogen). Preimmunization sera from the same guinea pig that produced 
Results
Morphology of cells grown in the 3-D culture system
To investigate the morphological characteristics of mature intestinal cell aggregates, we observed them microscopically after being cultured for 3-4 weeks and harvested from a RWV. Both INT-407 cells and Caco-2 cells adhered efficiently to the microcarrier beads and formed 3-D tissue-like aggregates, ranging from 2 to 4 mm in diameter (Fig. 1a, e) . Each aggregate possessed *10 microcarrier beads and multilayers of cells (Fig. 1b, f) . The surface of each cell aggregate had apical microvilli that were clearly seen with both light (91,000) (Fig. 1c, g ) and electron microscopes (910,000) (Fig. 1d, h ). Compared to the INT-407 cells, the microvilli of the Caco-2 cells were more numerous and slightly longer, and morphologically, they more closely resembled the brush border of human intestine epithelial cells [32] .
Immunofluorescence assay GII.12/HS206. All of the stool samples were negative for other common diarrheal viruses (human rotavirus groups A, B and C, sapovirus, astrovirus, and adenovirus) as confirmed by RT-PCR or PCR. We performed comprehensive analysis in combinations of two cell lines inoculated with one of three genotypes and observed that *1 % of the cells stained positive for viral capsid protein (VP1) in INT-407 cells inoculated with GII.4/HS194 (Fig. 2, left) and GII.12/HS206 (Fig. 2, middle) , and in Caco-2 cells inoculated with GI.1/Norwalk (Fig. 2, right) . By co-localization analysis with DAPI staining, the locations of these positive signals were found to be outside of the nucleus. To further investigate the location of the viral antigen-positive signals, we performed an orthoslice analysis by confocal microscopy. Although a few signals appeared to be in the cells (under the cytoskeleton-actin filaments), the majority of the signals were outside of the cells. A typical case was captured in INT-407 cells inoculated with GII.12/HS206 strain ( Fig. 3) , showing the VP1 signal (red) above the cytoskeleton signal (cyan). These results suggested that the viral capsid protein VP1 was mainly located on the surface of the cells.
Monitoring of viral RNA by TaqMan RT-qPCR Next, we examined whether viral RNA replication could be observed by titrating viral RNA in the supernatants (released and input virus) and cell lysates (cell-associated and intracellular virus) at multiple time points after inoculation with *10 7 GE/ml of HuNoV. Typical results from multiple trials for each of the three tested genotypes of HuNoVs in the Caco-2 and INT-407 cell lines are shown in Fig. 4 . We consistently detected HuNoV RNA both in supernatants (*10 5 -10 7 GE/ml) and cell lysate samples (*10 1 -10 3 GE/lg of total RNA from cell lysates), but never in the mock control samples (medium only; data not shown). However, the viral RNA levels did not increase at any time points assayed, remaining at a plateau or declining, and the viral RNA in the supernatants did not surpass the input HuNoV RNA level. Additional trials with the direct inoculation method and culture supplements in the medium are summarized in Table 1 . There was no significant increase in viral RNA at 24 hpi for any combination tested. These data suggest that although some HuNoVs might have attached or entered the cells after inoculation, were constructed digitally in the XZ and YZ planes, shown as horizontal and vertical lines in the XY plane. Red, HuNoV capsid proteins detected using guinea pig anti-GII.12 polyclonal antibody; cyan, cytoskeleton actin filaments detected using Alexa Fluor633-labeled phalloidin; blue, nuclei stained using DAPI they did not productively replicate to show dynamically increasing viral RNA titers.
Discussion
For more than four decades after the discovery of HuNoVs, an understanding of their life cycle and the development of antiviral drugs have been hampered due to lack of an efficient cell culture system to propagate these viruses. Significant efforts have been made to overcome this obstacle. Representative studies were summarized by Duizer et al. [10] , who tested HuNoV cultivation with more than 25 human and animal cell lines in various in vitro culture conditions but failed to replicate the virus. In 2007, Straub et al. [37] reported, for the first time, that HuNoV replicated in INT-407 cells using a 3-D RWV cell culture system. Although several researchers had questioned the validity of this study [6] , we were motivated to re-evaluate the significance of the 3-D RWV system for two reasons. First, the 3-D RWV system was confirmed to be a more physiologically relevant cell culture system compared to conventional 2-D cultures, and it has been successfully used to study the pathogenesis of other enteric bacterial and viral pathogens, including salmonella [18, 28] , hepatitis C virus [35] , and rhinovirus [26] . Second, a confirmatory paper published by Straub et al. [38] reported that Caco-2 cells cultured in a 3-D RWV also supported HuNoV replication.
In our study, we clearly showed the organoid structure of INT-407 and Caco-2 cell aggregates grown in the 3-D RWV for 21-28 days and confirmed the presence of the apical microvilli, especially on Caco-2 cells. These were described as critical features for the success of HuNoV propagation in a brush-border-producing Caco-2 cell line [38, 39] . However, in spite of the presence of microvilli on the cell aggregates, we did not observe measurable increases in viral RNA after inoculation with three different genotypes of HuNoVs. We attempted to monitor dynamic changes of viral RNA levels, which would be expected in the case of productive viral infection, by sampling additional time points (2-, 4-, 6-, 8-, 120-, 144-, 168-hpi) in some trials, but the viral titers resulted in a plateau or declined and were similar to that illustrated in Fig. 4 . These results provide clear evidence that in spite of the microvilli structures produced by intestinal cells grown in 3-D RWV, they failed to support the replication of the HuNoVs tested. This is in concordance with a recent paper Norovirus cell culture 263 [17] showing no increase of the viral RNA titer in Norwalk-virus-inoculated INT-407 cells up to 96 hpi. The GI.1/Norwalk-positive stool samples provided by Dr. Estes enabled us to compare the same HuNoV strain as inoculum in our HuNoV cell culture project with that conducted in different laboratories. The infectivity of these samples was well described in human volunteer studies [3] [4] [5] . Similarly, the infectivity of the other two genotype samples, namely GII.4/HS194 and GII.12/HS206, was confirmed by the studies using the gnotobiotic (Gn) pig model for HuNoV replication [20, 41] . The selection of well-characterized samples enabled us to use strain-specific antibodies, which greatly improved the sensitivity of the immunological assays. We detected *1 % of the cells staining positive at 24 hpi in both Caco-2 and INT-407 cell lines (Fig. 2) . The pattern of the signals, especially in Caco-2 cells inoculated with GI.1 shown in Fig. 2 , was unexpected, as we observed a whole cell surface labeled with antibody. There are two possible explanations for this configuration of signals. The first is localized viral replication, which is theoretically possible but was not supported by the RT-qPCR results. The second possibility is that the beating of microvilli on these polarized cells has caused the localized accumulation of inoculum virus without infection. This possibility was partially supported by the result of our pilot experiment using heat-inactivated (56°C, 1 hour) virus as inoculum, which occasionally showed accumulated signals in a single cell (data not shown). This possibility could be further tested by specific labeling of microvilli to investigate the locational relationship between viral antigen and microvilli. By orthoslice analysis, we showed that the positive signals remained on the surface of the inoculated cells, suggesting that the entry of the virus into the cells may have been blocked (Fig. 3) . Strong expression of HBGA H1 and H2 antigens and weak expression of H1 antigen was observed on the surface of Caco-2 and INT-407 cells, respectively (data not shown), and this is in concordance with previous studies [2, 14, 17] . Guix et al. [14] reported that overexpression of the FUT2 gene, which determines the secretor phenotype of HBGA, in human hepatoma Huh7 cells enhanced Norwalk virus attachment, but entry and replication were not observed. Their report and our observations suggest that some steps other than viral attachment may have been hampered, precluding productive viral replication in the cell lines tested.
By light and electron microscopic analysis, extensive attempts were made to document the presence of HuNoV particles and cytopathic effects (CPE) described by Straub et al. [37, 38] , such as vacuolization in the cytoplasm and shortening of microvilli. However, our observations were contradictory to their reports, i.e., neither HuNoV particles nor CPE were observed in the inoculated cells at 24 hpi (data not shown). The contrary findings could be due to different experimental conditions, such as different cell passages of INT-407 and Caco-2 cells, a different clone of Caco-2 cells, and different passages of GI.1/Norwalk virus used as inoculum. Nevertheless, the propagation of HuNoVs is still extremely difficult, even in well-established labs.
We also explored other possibility of using the 3-D RWV system to promote HuNoV replication, which was not examined by Straub's group. These attempts included the following: (1) direct virus inoculation onto cells and cell aggregates inside RWV, which was effective with rhinovirus [26] and HCV replication [35] ; (2) including culture supplements that were effective for the growth of fastidious enteric viruses in vitro (IC from non-infected Gn pigs [12, 30] , bile acid GCDCA [7] , and simvastatin [8, 20, 33] ); and (3) blind passage by retaining one fifth of the inoculated cells from the previous RWV to the following one. None of the trials showed evidence of HuNoV replication (Table 1) .
Collectively, the INT-407 and Caco-2 cells grew and differentiated to produce apical microvilli in 3-D RWV, but these cells did not support the replication of any of the three HuNoV strains. These results are contradictory to the previous reports [37, 38] . Future efforts could target the use of human primary intestinal cells and human small-intestinal organs to attempt to grow HuNoVs in vitro. The intrinsic ethical issues in these methods could be overcome by using an intestinal organoid model derived from human pluripotent stem cells, as has been done successfully in a rotavirus infection study [11] , and an induced pluripotent stem cell technology that might enable the production of a small-intestinal counterpart [40] .
